Because it was shown that oxidants can amplify GSIS and persistent activation of Nrf2 decreases glucose-triggered ROS signaling insulin release, this study points out on distinct roles that Nrf2 may play in pancreatic β-cell dysfunction that accompanies different stages of diabetes. This evidence concerns the gene INS and diabetes mellitus.